1. 23 Jan 2013  |  North America  |  Market Research

    Analysis of the European HIV Drugs Market

    Increasing Adoption of Oral Combination-pills for Treatment Boosts Market Growth

    Dyslipidemia exists in many forms and is prevalent in developed regions. Although many patients with moderately elevated lipids are well served by available therapies, there is a significant patient population for whom these therapies are inappropriate or inadequate, thereby prompting development of innovative therapies to fill the gaps. This res...

    $4,950.00

    Special Price $3,712.50 save 25 %

  2. 27 Jan 2003  |  North America  |  Market Research

    U.S. HIV/AIDS Therapies Markets

     

    The U.S. HIV/AIDS Therapies Markets report covers the various antiretroviral (ARV) drugs that are currently available in the U.S. namely, NRTIs, PIs and NNRTIs. The report also covers the pipeline drugs from the existing and novel ARV categories, and the HIV vaccines pipeline. Frost & Sullivan Market Engineering Analysis, major market/technology tr...

    $2,450.00

    Special Price $1,837.50 save 25 %

  3. 23 Dec 2002  |  North America  |  Market Research

    U.S. HIV Diagnostics and Monitoring Markets

     

    The U.S. HIV Diagnostics and Monitoring Market report focuses on the dynamic and increasingly complex area of HIV diagnostics assays implemented to facilitate disease management. This report covers the Diagnostics, Viral Load Monitoring, Genotyping/Phenotyping, and CD4/CD8 Cell Monitoring segments of the market. This report provides an in-depth ana...

    $2,450.00

    Special Price $1,837.50 save 25 %

  4. 15 Mar 2000  |  North America  |  Market Research

    United States HIV Diagnostic and Monitoring Markets

     

     

    $3,950.00

    Special Price $2,962.50 save 25 %

  5. 05 Aug 1999  |  North America  |  Market Research

    United States HIV/AIDS Therapeutic Markets

     

     

    $3,950.00

    Special Price $2,962.50 save 25 %